肝硬化门静脉高压脾切除术后门静脉血栓形成的预测因素分析

牟思玉; 杨哲; 吴力群; 邱轩; 郭珈铭

doi:10.3969/j.issn.1001-5256.2018.01.022

肝硬化门静脉高压脾切除术后门静脉血栓形成的预测因素分析

DOI: 10.3969/j.issn.1001-5256.2018.01.022

青岛大学附属医院

详细信息

中图分类号: R657.31
计量
- 文章访问数: 2175
- HTML全文浏览量: 43
- PDF下载量: 449
- 被引次数: 0
出版历程
- 出版日期: 2018-01-20

Predictive factors for portal vein thrombosis after splenectomy in cirrhotic patients with portal hypertension

The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266000, China

摘要

摘要:
目的探讨肝硬化门静脉高压患者接受脾切除断流术后门静脉血栓形成的原因。方法回顾性分析2012年1月-2016年8月青岛大学附属医院收治的123例脾切除断流术后患者临床资料,根据术后门静脉血栓发生与否分为血栓组与非血栓组。计量资料组间比较采用t检验,计数资料组间比较采用χ2检验。采用logistic回归模型进行多因素分析,受试者工作特征曲线下面积（AUC）比较影响因素预测价值。结果 37例脾切除断流术后患者发生门静脉血栓,发生率为30.08%。血栓组与非血栓组单因素分析结果显示,术前BMI（t=2.291）、MELD评分（t=1.852）、门静脉直径（t=1.982）、脾静脉直径（t=2.582）、肠系膜上静脉直径（t=2.186）、脾静脉流速（t=2.109）、脾蒂切除方式（χ2=4.505）比较,差异均有统计学意义（P值均<0.05）;肝功能Child-Pugh A级患者血栓组与非血栓组比较显示,脾静脉直径、肠系膜上静脉直径、门静脉直径、术前BMI组间差异有统计学意义（t值分别为2.347、2.654、2.312、2.187,P值均&l...
- 高血压,门静脉 /
- 脾切除术 /
- 静脉血栓形成 /
- 危险因素
Abstract:
Objective To investigate the cause of portal vein thrombosis ( PVT) after esophagogastric devascularization and splenectomy in cirrhotic patients with portal hypertension ( PH) . Methods A retrospective analysis was performed for the clinical data of 123 patients who were admitted to The Affiliated Hospital of Qingdao University from January, 2012 to August, 2016 and underwent esophagogastric devascularization and splenectomy, and according to the presence or absence of PVT after surgery, these patients were divided into PVT group and non-PVT group. The t-test was used for comparison of continuous data between groups, and the chi-square test was used for comparison of categorical data between groups. The logistic regression model was used for multivariate analysis, and the area under the curve ( AUC) was used to compare the predictive value of influencing factors. Results Of all patients, 37 experienced PVT after esophagogastric devascularization and splenectomy, resulting in an incidence rate of 30. 08% . The univariate analysis of the PVT group and the non-PVT group showed that there were significant differences between the two groups in preoperative body mass index ( BMI) ( t = 2. 291, P < 0. 05) , Model for End-Stage Liver Disease ( MELD) score ( t = 1. 852, P < 0. 05) , portal vein diameter ( t = 1. 982, P < 0. 05) , splenic vein diameter ( t = 2. 582, P < 0. 05) , superior mesenteric vein diameter ( t = 2. 186, P < 0. 05) , flow rate of the splenic vein ( t = 2. 109, P < 0. 05) , and method for the resection of the splenic pedicle ( χ2= 4. 505, P < 0. 05) . As for Child-Pugh class A patients, there were significant differences between the PVT group and the non-PVT group in splenic vein diameter, superior mesenteric vein diameter, portal vein diameter, and preoperative BMI ( t = 2. 347, 2. 654, 2. 312, and 2. 187, all P < 0. 05) . The multivariate logistic regression analysis showed that BMI ( odds ratio [OR]= 0. 859, 95% confidence interval [CI]: 0. 750-0. 983, P = 0. 027) , splenic vein diameter ( OR = 1. 191, 95% CI:1. 035-1. 370, P = 0. 015) , flow rate of the splenic vein ( OR = 1. 125, 95% CI: 1. 004-1. 262, P = 0. 043) , superior mesenteric vein diameter ( OR = 1. 202, 95% CI: 1. 001-1. 444, P = 0. 048) , and primary splenic pedicle resection ( OR = 2. 815, 95% CI: 1. 056-7. 503, P = 0. 039) were independent risk factors for PVT after surgery. Preoperative BMI < 22. 54 kg/m2 ( sensitivity 75. 9% and specificity 58. 3% ) or preoperative splenic vein diameter > 11. 5 mm ( sensitivity 72. 7% and specificity 62. 9% ) suggested a higher risk of PVT after esophagogastric devascularization and splenectomy. Conclusion Preoperative splenic vein diameter and BMI are associated with PVT after surgery, and monitoring of these two indices helps to predict PVT in the early stage.
- hypertension, portal /
- splenectomy /
- venous thrombosis /
- risk factors

HTML全文

参考文献(26)

[1]HUANG ZJ, ZHOU MG, WANG LJ.Study on the geographic distribution of liver cancer mortality and Hbs Ag carrier rate in China[J].Dis Surveill, 2007, 22 (4) :242-245. (in Chinese) 黄正京, 周脉耕, 王黎君.中国肝癌死亡率和乙肝病毒表面抗原携带率的地理分布研究[J].疾病监测, 2007, 22 (4) :242-245.

[2]BANDALI MF, MIRAKHUR A, LEE EW, et al.Portal hypertension:Imaging of portosystemic collateral pathways and associated image-guided therapy[J].World J Gastroenterol, 2017, 23 (10) :1735-1746.

[3]TANG W, WANG Y, ZHAO XY, et al.Impact of portal vein thrombosis on prognosis of patients with liver cirrhosis[J].J Clin Hepatol, 2017, 33 (3) :466-471. (in Chinese) 汤雯, 王宇, 赵新颜, 等.门静脉血栓对肝硬化患者预后的影响[J].临床肝胆病杂志, 2017, 33 (3) :466-471.

[4]WANG G, LENG XS.Portal hypertension surgery in China[J/CD].Chin J Oper Proc Gen Surg:Electronic Version, 2009, 3 (3) :578-583. (in Chinese) 王刚, 冷希圣.我国门静脉高压症外科治疗现状与前景[J/CD].中华普外科手术学杂志:电子版, 2009, 3 (3) :578-583.

[5]MEI B, LIU FL, CHEN XP, et al.Prevention of low molecular weight heparins, which was early administrated after devascularization operation, on thrombosis of portal vein[J].Chin J Exp Surg, 2005, 22 (12) :1467-1468. (in Chinese) 梅斌, 刘飞龙, 陈孝平, 等.低分子肝素早期使用预防断流术后门静脉系血栓形成[J].中华实验外科杂志, 2005, 22 (12) :1467-1468.

[6]JIANG GQ, BAI DS, QIAN JJ, et al.Clinical efficacy of warfarin in preventing portal vein thrombosis after modified laparoscopic splenectomy combined with pericardial devascularization[J].Chin J Dig Surg, 2016, 15 (1) :71-74. (in Chinese) 蒋国庆, 柏斗胜, 钱建军, 等.华法林防治改良腹腔镜脾切除联合贲门周围血管断流术后门静脉血栓的临床疗效[J].中华消化外科杂志, 2016, 15 (1) :71-74.

[7]BAO HK, WEI XL.Comparisons of clinical effect of hand-assisted laparoscopic and open splenectomy combined with pericardial devasculariza-tion for the treatment of portal hypertension in liver cirrhosis[J].Chin J Med Offic, 44 (1) :92-94, 97. (in Chinese) 包汉康, 韦秀丽.手助腹腔镜与开腹脾切除贲门周围血管离断术治疗肝硬化门脉高压症的疗效比较[J].临床军医杂志, 44 (1) :92-94, 97.

[8]HE S, HE F.Predictive model of portal venous system thrombosis in cirrhotic portal hypertensive patients after splenectomy[J].Int J Clin Exp Med, 2015, 8 (3) :4236-4242.

[9]OGREN M, BERGQVIST D, BJORCK M, et al.Portal vein thrombosis:prevalence, patient characteristics and lifetime risk:a population study based on 23, 796 consecutive autopsies[J].World J Gastroenterol, 2006, 12 (13) :2115-2119.

[10]TRIPODI A, ANSTEE QM, SOGAARD KK, et al.Hypercoagulability in cirrhosis:causes and consequences[J].J Thromb Haemost, 2011, 9 (9) :1713-1723.

[11]OKUDA K, OHNISHI K, KIMURA K, et al.Incidence of portal vein thrombosis in liver cirrhosis.An angiographic study in 708 patients[J].Gastroenterology, 1985, 89 (2) :279-286.

[12]YAMASHITA Y, BEKKI Y, IMAI D, et al.Efficacy of postoperative anticoagulation therapy with enoxaparin for portal vein thrombosis after hepatic resection in patients with liver cancer[J].Thromb Res, 2014, 134 (4) :826-831.

[13]FRANCOZ C, BELGHITI J, VILGRAIN V, et al.Splanchnic vein thrombosis in candidates for liver transplantation:usefulness of screening and anticoagulation[J].Gut, 2005, 54 (5) :691-697.

[14]LI L.Risk factors of portal vein thrombosis in cirrhotic patients from the view of Virchow's triad[J].J Pract Hepatol, 2015, 18 (3) :325-328. (in Chinese) 李玲.从Virchow三要素分析肝硬化患者发生门静脉血栓危险因[J].实用肝脏病杂志, 2015, 18 (3) :325-328.

[15]WANG MC, TIAN B, WANG GN, et al.Risk factors of portal vein thrombosis after splenectomy in cirrhotic patients:a Meta-analysis[J].Chin J Hepatobiliary Surg, 2014, 20 (12) :855-861. (in Chinese) 王满才, 田斌, 王根年, 等.肝硬化脾切除术后门静脉血栓形成相关因素的Meta分析[J].中华肝胆外科杂志, 2014, 20 (12) :855-861.

[16]WU S, WU Z, ZHANG X, et al.The incidence and risk factors of portal vein system thrombosis after splenectomy and pericardial devascularization[J].Turk J Gastroenterol, 2015, 26 (5) :423-428.

[17]LI MX, ZHANG XF, LIU ZW, et al.Risk factors and clinical characteristics of portal vein thrombosis after splenectomy in patients with liver cirrhosis[J].Hepatobiliary Pancreat Dis Int, 2013, 12 (5) :512-519.

[18]FEI Y, ZONG GQ, CHEN J, et al.Evaluation the value of markers for prediction of portal vein thrombosis after devascularization[J].Ann Hepatol, 2015, 14 (6) :856-861.

[19]KINJO N, KAWANAKA H, AKAHOSHI T, et al.Portal vein thrombosis in liver cirrhosis[J].World J Hepatol, 2014, 6 (2) :64-71.

[20]ZOCCO MA, di STASIO E, de CRISTOFARO R, et al.Thrombotic risk factors in patients with liver cirrhosis:correlation with MELD scoring system and portal vein thrombosis development[J].J Hepatol, 2009, 51 (4) :682-689.

[21]XU GS, XU CL, YU B, et al.A multivariate analysis of portal vein thrombosis after devascularization for portal hypertension[J].World Latest Med Inf, 2015, 15 (40) :76-77. (in Chinese) 徐国森, 徐长禄, 于波, 等.门静脉高压症断流术后门静脉血栓形成的多因素分析[J].世界最新医学信息文摘, 2015, 15 (40) :76-77.

[22]WEI SH, WU HR.Portal vein thrombosis after splenectomy:an analysis of 10 cases[J].Chin J Gen Surg, 2006, 21 (3) :228-229. (in Chinese) 危少华, 吴浩荣.脾切除术后静脉血栓形成十例分析[J].中华普通外科杂志, 2006, 21 (3) :228-229.

[23]GAO F, WU DQ, LI GL.Clinical application of in situ secondary splenic pedicle dissection in splenectomy[J].J Hepatopancreatobiliary Surg, 2009, 21 (5) :386-387. (in Chinese) 高峰, 吴德全, 李国良.原位二级脾蒂离断脾切除术的临床应用[J].肝胆胰外科杂志, 2009, 21 (5) :386-387.

[24]GUO YY.The clinical value of D-dimer in cirrhotic patients with portal venous thrombosis[J].J Clin Hepatol, 2010, 26 (3) :304-305. (in Chinese) 郭银燕.D-二聚体在诊断肝硬化门静脉血栓形成中的应用价值[J].临床肝胆病杂志, 2010, 26 (3) :304-305.

[25]DING HG, WANG JT, WANG BE.Dystrophy, abnormal energy metabolism, nutritional support in cirrhotic patients[J].Chin J Clin Nutr, 2002, 10 (4) :281-283. (in Chinese) 丁惠国, 汪俊韬, 王宝恩.肝硬化患者营养不良, 能量代谢异常与营养支持[J].中国临床营养杂志, 2002, 10 (4) :281-283.

[26]CAMPILLO B, RICHARDET JP, BORIES PN.Validation of body mass index for the diagnosis of malnutrition in patients with liver cirrhosis[J].Gastroenterol Clin Biol, 2006, 30 (10) :1137-1143.

施引文献

资源附件(0)

访问统计